Figure 3.
In vivo efficacy of combined irradiation (2 Gy for five consecutive days, 5 days/week for 2 weeks starting on day 2), capecitabine (359 mg/kg per day, 5 days/week for 2 weeks starting on day 1), and oxaliplatin (10 mg/kg, days 2 and 9) against human colon cancer HT29 xenografts in nude mice: (A) control, (B) capecitabine, and (C) capecitabine and oxaliplatin. All left-sided tumors received additional radiotherapy.